Vimarsana
Biggest News Aggregation in the World

Michael Ison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Ison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Ison Today - Breaking & Trending Today

Lifetime Achievement, Pioneer Awards presented at American Transplant Congress - Vimarsana News

Lifetime Achievement, Pioneer Awards presented at American Transplant Congress

PHILADELPHIA — Organizers of the American Transplant Congress announced award winners in transplantation research and achievements, including the Pioneer Award and the Lifetime Achievement Award.The awards were presented here on behalf of the American Society of Transplantation (AST), American Society of Transplant Surgeons (ASTS) and the American Journal of Transplantation.

Source: healio.com
RSV Vaccine Maintains Efficacy Across Two Seasons in Seniors - Vimarsana News

RSV Vaccine Maintains Efficacy Across Two Seasons in Seniors

But another jab after 1 year proved less meaningful in AReSVi-006 trial

Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023 - Vimarsana News

Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023

This report describes the Advisory Committee on Immunization Practices' recommendation that all people aged 6 months and older get an updated COVID-19 vaccine.

Source: cdc.gov
Sharon Ison | Obituary | The Independent - Vimarsana News

Sharon Ison | Obituary | The Independent

Sharon Ison passed away. This is the full obituary where you can share condolences and memories. Published in the The Independent on 2023-09-21.

Vaccine Candidates for RSV Ward Off Severe Illness in Older Adults - Vimarsana News

Vaccine Candidates for RSV Ward Off Severe Illness in Older Adults

Trials show upwards of 85% protection against more severe cases of respiratory syncytial virus